Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration

Recruiting now

Conditions studied: Metastatic Prostate Cancer (mPC)

In brief

Implementation of a new algorithm for HRR gene mutation testing in patients with mPC through liquid biopsy integration

Key facts

Study ID

NCT06762379

Run by

European Institute of Oncology

People needed

125

Starts

2024-12-20

Expected to finish

2030-12-31

Last updated by the study team

2026-03-24

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients with metastatic prostate cancer whose tumor tissue is unavailable or inadequate for molecular testing. • Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.

You may not qualify if…

• Unable to provide written informed consent

Where it is running

• European Institute of oncology — Milan, Italy, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.